News | February 05, 2015

IBA Dosimetry’s CAREprogram Supports the UICC and World Cancer Day 2015

Activities are planned to raise awareness of the importance of World Cancer Day

IBA (Ion Beam Applications S.A.), a global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, is proud to support the Union for International Cancer Control (UICC) by participating in World Cancer Day on February 4, 2015.  IBA’s mission to “Protect, Enhance and Save Lives” reflects the understanding that lives are impacted by the efforts of all of IBA’s employees in developing the solutions, education and services for fighting cancer. World Cancer Day offers the perfect platform to take a moment and focus on this cause from a very personal aspect.

“Cancers figure among the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer related deaths in 2012”. The number of new cancer cases is expected to increase to 24 million by 2035” according to the UICC.  “Unless urgent action is taken to raise awareness about cancer and develop practical strategies to address the disease, millions of people will continue to die. Sadly, the greatest increase in cancer is projected to hit low- and middle-income countries, those least equipped to cope with the social and economic impact of the disease.”

IBA Dosimetry’s activities to support World Cancer Day include an internal awareness campaign, participation in World Cancer Day 2015 Thunderclap (a global social media blast), hosting a Healthy Choices Lunch, and encouraging employees to sign up for a “Do Something!” challenge. The “Do Something!” challenge gives people the opportunity to make intentional choices that support the goals of the Word Cancer Declaration agenda. By committing to make healthier food choices, quit smoking, start a fitness program or support any of the many cancer foundations there is something that everyone can do.  The theme for this year’s World Cancer Day is “Not Beyond Us.” 

“When cancer hits a family, life changes on the spot and often drastically,” said Rob Plompen, president of IBA Dosimetry. “During my past 17 years at IBA Dosimetry, I have had the opportunity to visit many cancer centers around the world. Whether in highly equipped Radiation Therapy centers or in less developed countries, the passion of the professionals I met working in every center is a common one: to fight this evil disease and, above all, to provide a better quality of life for their patients. At IBA Dosimetry, more than 220 employees support these professionals every day in their battle against cancer.  By providing Quality Assurance equipment, education and services to ensure safe treatment of patients, we are proud of this mission and fortunate that we can contribute in the joint battle to defeat cancer. It’s Not Beyond Us.”

“We are witnessing an unavoidable increase in the number of cancer cases throughout the world.To defeat this terrible disease, healthcare specialists need the best solutions to diagnose and treat cancer. Proton therapy is one of those solutions. It is considered as the most advanced treatment to fight against cancer. Day after day, together with our partners in oncology, we strive to make proton therapy accessible to as many patients as possible worldwide as it reduces side effects and improve considerably the quality of life. These two advantages are particularly important to ensure a bright future for children. At IBA, we are developing innovative solutions to push  back the limits of technology and complete our mission to Protect, Enhance and Save Lives. Cancer is not beyond us!” added Olivier Legrain, chief executive officer of IBA.

IBA is committed to continuing its education and advocacy to ensure that all cancer patients and their families are aware of the technologies and treatments available to them. 

For more information: www.iba-dosimetry.com

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init